162 related articles for article (PubMed ID: 10376579)
1. Encouraging news from the SERM frontier. Selective estrogen receptor modulator.
Franks AL; Steinberg KK
JAMA; 1999 Jun; 281(23):2243-4. PubMed ID: 10376579
[No Abstract] [Full Text] [Related]
2. Antiestrogenic action of raloxifene and tamoxifen: today and tomorrow.
Jordan VC
J Natl Cancer Inst; 1998 Jul; 90(13):967-71. PubMed ID: 9665143
[No Abstract] [Full Text] [Related]
3. Raloxifene: a selective estrogen receptor modulator.
Scott JA; Da Camara CC; Early JE
Am Fam Physician; 1999 Sep; 60(4):1131-9. PubMed ID: 10507743
[TBL] [Abstract][Full Text] [Related]
4. Of designer drugs, magic bullets, and gold standards.
Rifkind BM; Rossouw JE
JAMA; 1998 May; 279(18):1483-5. PubMed ID: 9600485
[No Abstract] [Full Text] [Related]
5. Selective estrogen receptor modulators and phytoestrogens: new therapies for the postmenopausal women.
Fitzpatrick LA
Mayo Clin Proc; 1999 Jun; 74(6):601-7. PubMed ID: 10377937
[TBL] [Abstract][Full Text] [Related]
6. In search of the perfect SERM: beyond tamoxifen and raloxifene.
McNeil C
J Natl Cancer Inst; 1998 Jul; 90(13):956-7. PubMed ID: 9665139
[No Abstract] [Full Text] [Related]
7. Designer estrogens.
Jordan VC
Sci Am; 1998 Oct; 279(4):60-7. PubMed ID: 9768522
[No Abstract] [Full Text] [Related]
8. Raloxifene provides an alternative for osteoporosis prevention.
Willhite SL; Goebel SR; Scoggin JA
Ann Pharmacother; 1998; 32(7-8):834-7. PubMed ID: 9681100
[No Abstract] [Full Text] [Related]
9. Tamoxifen, raloxifene findings unlikely to encourage genetic screening for breast cancer.
Dove A
Nat Med; 1998 Jun; 4(6):647. PubMed ID: 9623955
[No Abstract] [Full Text] [Related]
10. Raloxifene, a new selective estrogen receptor modulator.
Goldfrank D; Haytoglu T; Frishman WH; Mohammad Z
J Clin Pharmacol; 1999 Aug; 39(8):767-74. PubMed ID: 10434227
[TBL] [Abstract][Full Text] [Related]
11. Selective estrogen receptor modulators and postmenopausal women's health: the promise for the next millennium.
Agnusdei D
Aging (Milano); 1998 Aug; 10(4):269-72. PubMed ID: 9825017
[No Abstract] [Full Text] [Related]
12. Estrogen receptor as a target for the prevention of breast cancer.
Jordan VC
J Lab Clin Med; 1999 May; 133(5):408-14. PubMed ID: 10235123
[No Abstract] [Full Text] [Related]
13. Gonadal hormone substitutes: effects on the cardiovascular system.
Clarkson TB; Cline JM; Williams JK; Anthony MS
Osteoporos Int; 1997; 7 Suppl 1():S43-51. PubMed ID: 9205646
[No Abstract] [Full Text] [Related]
14. Clinical effects of raloxifene hydrochloride in women.
Khovidhunkit W; Shoback DM
Ann Intern Med; 1999 Mar; 130(5):431-9. PubMed ID: 10068418
[TBL] [Abstract][Full Text] [Related]
15. Selective estrogen receptor modulators: an alternative to hormone replacement therapy.
Bryant HU; Dere WH
Proc Soc Exp Biol Med; 1998 Jan; 217(1):45-52. PubMed ID: 9421206
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen, raloxifene, and the prevention of breast cancer.
Jordan VC; Morrow M
Endocr Rev; 1999 Jun; 20(3):253-78. PubMed ID: 10368771
[No Abstract] [Full Text] [Related]
17. HRT and SERMS--increasing benefit, reducing risk?
Jackson G
Int J Clin Pract; 1998; 52(1):3. PubMed ID: 9536557
[No Abstract] [Full Text] [Related]
18. Selective oestrogen receptor modulators: potential therapeutic applications.
Compston JE
Clin Endocrinol (Oxf); 1998 Apr; 48(4):389-91. PubMed ID: 9640402
[No Abstract] [Full Text] [Related]
19. Raloxifene hydrochloride, a selective estrogen receptor modulator: safety assessment of effects on cognitive function and mood in postmenopausal women.
Nickelsen T; Lufkin EG; Riggs BL; Cox DA; Crook TH
Psychoneuroendocrinology; 1999 Jan; 24(1):115-28. PubMed ID: 10098223
[TBL] [Abstract][Full Text] [Related]
20. Raloxifene: magic bullet for heart and bone?
Gustafsson JA
Nat Med; 1998 Feb; 4(2):152-3. PubMed ID: 9461183
[No Abstract] [Full Text] [Related]
[Next] [New Search]
